138 related articles for article (PubMed ID: 22858217)
1. Increased serum matrix metalloproteinase-9 (MMP-9) levels in young patients during bipolar depression.
Rybakowski JK; Remlinger-Molenda A; Czech-Kucharska A; Wojcicka M; Michalak M; Losy J
J Affect Disord; 2013 Apr; 146(2):286-9. PubMed ID: 22858217
[TBL] [Abstract][Full Text] [Related]
2. Functional polymorphism of matrix metalloproteinase-9 (MMP-9) gene and response to lithium prophylaxis in bipolar patients.
Rybakowski JK; Skibinska M; Suwalska A; Leszczynska-Rodziewicz A; Kaczmarek L; Hauser J
Hum Psychopharmacol; 2011 Mar; 26(2):168-71. PubMed ID: 21437990
[TBL] [Abstract][Full Text] [Related]
3. Matrix metalloproteinase-9 gene and bipolar mood disorder.
Rybakowski JK; Skibinska M; Leszczynska-Rodziewicz A; Kaczmarek L; Hauser J
Neuromolecular Med; 2009; 11(2):128-32. PubMed ID: 19536654
[TBL] [Abstract][Full Text] [Related]
4. Abnormality in serum levels of mature brain-derived neurotrophic factor (BDNF) and its precursor proBDNF in mood-stabilized patients with bipolar disorder: a study of two independent cohorts.
Södersten K; Pålsson E; Ishima T; Funa K; Landén M; Hashimoto K; Ågren H
J Affect Disord; 2014 May; 160():1-9. PubMed ID: 24709015
[TBL] [Abstract][Full Text] [Related]
5. Altered Serum Levels of Matrix Metalloproteinase-2, -9 in Response to Electroconvulsive Therapy for Mood Disorders.
Shibasaki C; Takebayashi M; Itagaki K; Abe H; Kajitani N; Okada-Tsuchioka M; Yamawaki S
Int J Neuropsychopharmacol; 2016 Sep; 19(9):. PubMed ID: 26912606
[TBL] [Abstract][Full Text] [Related]
6. Expression of matrix metalloproteinases in patients with bipolar disorder.
Chiarani F; Fries GR; Stertz L; Ceresér KM; Wyse AT; Kapczinski FP; Kunz M
Braz J Psychiatry; 2013; 35(4):375-9. PubMed ID: 24402212
[TBL] [Abstract][Full Text] [Related]
7. Decreased serum zinc concentration during depressive episode in patients with bipolar disorder.
Siwek M; Sowa-Kućma M; Styczeń K; Szewczyk B; Reczyński W; Misztak P; Topór-Mądry R; Nowak G; Dudek D; Rybakowski JK
J Affect Disord; 2016 Jan; 190():272-277. PubMed ID: 26540081
[TBL] [Abstract][Full Text] [Related]
8. Persistent inflammation and its relationship to leptin and insulin in phases of bipolar disorder from acute depression to full remission.
Tsai SY; Chung KH; Huang SH; Chen PH; Lee HC; Kuo CJ
Bipolar Disord; 2014 Dec; 16(8):800-8. PubMed ID: 25130211
[TBL] [Abstract][Full Text] [Related]
9. Glutamate-Related Antibodies and Peripheral Insulin-Like Growth Factor in Bipolar Disorder and Lithium Prophylaxis.
Ferensztajn-Rochowiak E; Kaczmarek M; Wójcicka M; Kaufman-Szukalska E; Dziuda S; Remlinger-Molenda A; Szeliga-Neymann A; Losy J; Rybakowski JK
Neuropsychobiology; 2019; 77(1):49-56. PubMed ID: 30336492
[TBL] [Abstract][Full Text] [Related]
10. Exploring the relationship between vitamin D and mania: correlations between serum vitamin D levels and disease activity.
Altunsoy N; Yüksel RN; Cingi Yirun M; Kılıçarslan A; Aydemir Ç
Nord J Psychiatry; 2018 Apr; 72(3):221-225. PubMed ID: 29308715
[TBL] [Abstract][Full Text] [Related]
11. Speech Understanding in Manic and Depressive Episodes of Mood Disorders.
Napierała M; Suwalska A; Pucher B; Rybakowski JK
J Neuropsychiatry Clin Neurosci; 2022; 34(4):414-421. PubMed ID: 35414193
[TBL] [Abstract][Full Text] [Related]
12. Antidepressant-associated mania or hypomania: a comparison with personality and bipolarity features of bipolar I disorder.
Saatcioglu O; Erim R; Tomruk N; Oral T; Alpay N
J Affect Disord; 2011 Nov; 134(1-3):85-90. PubMed ID: 21632117
[TBL] [Abstract][Full Text] [Related]
13. May oxytocin be a trait marker for bipolar disorder?
Turan T; Uysal C; Asdemir A; Kılıç E
Psychoneuroendocrinology; 2013 Dec; 38(12):2890-6. PubMed ID: 24080188
[TBL] [Abstract][Full Text] [Related]
14. Are ICAM, VCAM and E-selectin levels different in first manic episode and subsequent remission?
Turan C; Kesebir S; Süner O
J Affect Disord; 2014 Jul; 163():76-80. PubMed ID: 24836091
[TBL] [Abstract][Full Text] [Related]
15. The circadian system of patients with bipolar disorder differs in episodes of mania and depression.
Nováková M; Praško J; Látalová K; Sládek M; Sumová A
Bipolar Disord; 2015 May; 17(3):303-14. PubMed ID: 25359533
[TBL] [Abstract][Full Text] [Related]
16. Baseline characteristics and outcomes in patients with first episode or multiple episodes of acute mania.
Tohen M; Vieta E; Gonzalez-Pinto A; Reed C; Lin D;
J Clin Psychiatry; 2010 Mar; 71(3):255-61. PubMed ID: 19709503
[TBL] [Abstract][Full Text] [Related]
17. The McLean-Harvard First-Episode Mania Study: prediction of recovery and first recurrence.
Tohen M; Zarate CA; Hennen J; Khalsa HM; Strakowski SM; Gebre-Medhin P; Salvatore P; Baldessarini RJ
Am J Psychiatry; 2003 Dec; 160(12):2099-107. PubMed ID: 14638578
[TBL] [Abstract][Full Text] [Related]
18. Increased uric acid levels in bipolar disorder subjects during different phases of illness.
Albert U; De Cori D; Aguglia A; Barbaro F; Bogetto F; Maina G
J Affect Disord; 2015 Mar; 173():170-5. PubMed ID: 25462413
[TBL] [Abstract][Full Text] [Related]
19. The serum concentration of magnesium as a potential state marker in patients with diagnosis of bipolar disorder.
Siwek M; Styczeń K; Sowa-Kućma M; Dudek D; Reczyński W; Szewczyk B; Misztak P; Opoka W; Topór-Mądry R; Nowak G
Psychiatr Pol; 2015; 49(6):1277-87. PubMed ID: 26909402
[TBL] [Abstract][Full Text] [Related]
20. [Activity of selected cytokines in bipolar patients during manic and depressive episodes].
Remlinger-Molenda A; Wójciak P; Michalak M; Rybakowski J
Psychiatr Pol; 2012; 46(4):599-611. PubMed ID: 23214162
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
